Literature DB >> 10835299

Bayesian fine-scale mapping of disease loci, by hidden Markov models.

A P Morris1, J C Whittaker, D J Balding.   

Abstract

We present a new multilocus method for the fine-scale mapping of genes contributing to human diseases. The method is designed for use with multiple biallelic markers-in particular, single-nucleotide polymorphisms for which high-density genetic maps will soon be available. We model disease-marker association in a candidate region via a hidden Markov process and allow for correlation between linked marker loci. Using Markov-chain-Monte Carlo simulation methods, we obtain posterior distributions of model parameter estimates including disease-gene location and the age of the disease-predisposing mutation. In addition, we allow for heterogeneity in recombination rates, across the candidate region, to account for recombination hot and cold spots. We also obtain, for the ancestral marker haplotype, a posterior distribution that is unique to our method and that, unlike maximum-likelihood estimation, can properly account for uncertainty. We apply the method to data for cystic fibrosis and Huntington disease, for which mutations in disease genes have already been identified. The new method performs well compared with existing multi-locus mapping methods.

Entities:  

Mesh:

Year:  2000        PMID: 10835299      PMCID: PMC1287074          DOI: 10.1086/302956

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics.

Authors:  J L Serre; B Simon-Bouy; E Mornet; B Jaume-Roig; A Balassopoulou; M Schwartz; A Taillandier; J Boué; A Boué
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

2.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

3.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  DNA markers for nervous system diseases.

Authors:  J F Gusella; R E Tanzi; M A Anderson; W Hobbs; K Gibbons; R Raschtchian; T C Gilliam; M R Wallace; N S Wexler; P M Conneally
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

5.  Complex patterns of linkage disequilibrium in the Huntington disease region.

Authors:  M E MacDonald; C Lin; L Srinidhi; G Bates; M Altherr; W L Whaley; H Lehrach; J Wasmuth; J F Gusella
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

6.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  Likelihood methods for locating disease genes in nonequilibrium populations.

Authors:  N L Kaplan; W G Hill; B S Weir
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

8.  The origin of the major cystic fibrosis mutation (delta F508) in European populations.

Authors:  N Morral; J Bertranpetit; X Estivill; V Nunes; T Casals; J Giménez; A Reis; R Varon-Mateeva; M Macek; L Kalaydjieva
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

9.  A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci.

Authors:  J D Terwilliger
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

10.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

View more
  28 in total

1.  The optimal measure of allelic association.

Authors:  N E Morton; W Zhang; P Taillon-Miller; S Ennis; P Y Kwok; A Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Homozygosity and linkage disequilibrium.

Authors:  Chiara Sabatti; Neil Risch
Journal:  Genetics       Date:  2002-04       Impact factor: 4.562

3.  Joint linkage and linkage disequilibrium mapping of quantitative trait loci in natural populations.

Authors:  Rongling Wu; Chang-Xing Ma; George Casella
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

4.  Fine-scale mapping of disease loci via shattered coalescent modeling of genealogies.

Authors:  A P Morris; J C Whittaker; D J Balding
Journal:  Am J Hum Genet       Date:  2002-02-08       Impact factor: 11.025

5.  Fine mapping of complex trait genes combining pedigree and linkage disequilibrium information: a Bayesian unified framework.

Authors:  Miguel Pérez-Enciso
Journal:  Genetics       Date:  2003-04       Impact factor: 4.562

Review 6.  Genetic epidemiology, genetic maps and positional cloning.

Authors:  Newton E Morton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-10-29       Impact factor: 6.237

7.  Fine-scale mapping of disease genes with multiple mutations via spatial clustering techniques.

Authors:  John Molitor; Paul Marjoram; Duncan Thomas
Journal:  Am J Hum Genet       Date:  2003-11-20       Impact factor: 11.025

8.  Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data.

Authors:  Na Li; Matthew Stephens
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

9.  Hierarchical modeling of linkage disequilibrium: genetic structure and spatial relations.

Authors:  David V Conti; John S Witte
Journal:  Am J Hum Genet       Date:  2003-01-13       Impact factor: 11.025

10.  The impact of genomics on the study of natural variation in Arabidopsis.

Authors:  Justin O Borevitz; Magnus Nordborg
Journal:  Plant Physiol       Date:  2003-06       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.